1959:TSEKRAFTIA CORPORATION Analysis
Data as of 2026-06-12 - not real-time
₩42,550.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
HK inno.N is trading at 42,550 KRW, well below its 20‑day (44,247 KRW), 50‑day (48,055 KRW) and 200‑day (49,479 KRW) simple moving averages, signaling a bearish technical backdrop. The 14‑day RSI sits at 40.6, hinting at modest oversold pressure, while the MACD line remains under its signal, reinforcing downside momentum. Support sits around 37,300 KRW with resistance near 51,700 KRW, and the 30‑day volatility spikes at 42 %, suggesting price swings could be sharp. Yet the stock’s beta of ~0.8 points to lower systematic risk than the market overall.
Fundamentally, the forward P/E of 10.9 is dramatically cheaper than the industry average of 24.9, and the dividend yield of 0.98 % comes with a modest payout ratio of 14 %, indicating sustainability. Operating cash flow remains positive despite a recent free‑cash‑flow dip, and the debt‑to‑equity ratio of ~40 is high but manageable given the company’s cash reserves. Analysts project a target median price of 70,000 KRW, implying roughly 60 % upside from current levels, and the consensus recommendation is a “buy.”
Fundamentally, the forward P/E of 10.9 is dramatically cheaper than the industry average of 24.9, and the dividend yield of 0.98 % comes with a modest payout ratio of 14 %, indicating sustainability. Operating cash flow remains positive despite a recent free‑cash‑flow dip, and the debt‑to‑equity ratio of ~40 is high but manageable given the company’s cash reserves. Analysts project a target median price of 70,000 KRW, implying roughly 60 % upside from current levels, and the consensus recommendation is a “buy.”
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below key moving averages
- Bearish MACD and modest RSI pressure
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount to peers
- Sustainable dividend with low payout ratio
- Positive operating cash flow despite free‑cash‑flow dip
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic R&D pipeline and international expansion
- Undervalued forward P/E relative to industry
- Strong cash position to support growth initiatives
Key Metrics & Analysis
Financial Health
Revenue Growth5.10%
Profit Margin5.34%
P/E Ratio10.9
ROE3.90%
ROA2.11%
Debt/Equity39.75
Op. Cash Flow₩42.6B
Free Cash Flow₩-6628940800
Industry P/E24.9
Technical Analysis
TrendBearish
RSI40.6
Support₩37,300.00
Resistance₩51,700.00
MA 20₩44,247.50
MA 50₩48,055.00
MA 200₩49,479.25
MACDBearish
VolumeStable
Fear & Greed Index86.71
Valuation
Fair Value₩5,675.64
Target Price₩68,636.37
Upside/Downside61.31%
GradeUndervalued
TypeBlend
Dividend Yield0.98%
Risk Assessment
Beta0.81
Volatility42.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.